Updates on developments in HIV therapeutics.
Boyle
Brian A
BA
Department of International Medicine and Infectious Disease, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, USA.
D000328:Adult; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D009705:Nucleosides / Q000627:therapeutic use*; D009711:Nucleotides / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D011753:Pyrones / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013449:Sulfonamides
D017320:HIV Protease Inhibitors; D009705:Nucleosides; D009711:Nucleotides; D011725:Pyridines; D011753:Pyrones; D013449:Sulfonamides; C107201:tipranavir